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Background:  The  intrawound  application  of  vancomycin  powder  in  addition  to intravenous  administra-
tion  of  antibiotics  has  been  reported  to  be an  easy  and  cost-efﬁcient  technique  for  reducing  the  deep
infection,  which  is a serious  complication  of  spinal  surgeries.  The  aim of  the  present  meta-analysis  was
to derive  a  preliminary  estimation  on  the  clinical  performance  of  this  technique.
Hypothesis:  The  intrawound  application  of vancomycin  powder  in  addition  to intravenous  administration
of  antibiotics  may  signiﬁcantly  reduce  the  risk  of  deep  infection  after  spinal  surgeries.
Materials  and  methods:  Studies  were  identiﬁed  from  PubMed  and  EMBASE  searches.  After  comprehensive
review,  data  were  extracted  from  eligible  studies.  A  meta-analysis  was  performed  to generate  pooled  odds
ratio  (OR)  of  this  technique.
Results: Eight  studies  (4592  patients)  were  included.  The  pooled  OR (95%  CI)  was  0.22 (0.07–0.63).  I2
value  was  65.2%  (P = 0.005).  The  pooled  ORs were  stable  in sensitivity  analyses.  No  analysis  of  subgroup,
meta-regression  or  publication  bias  was performed  because  of  inadequate  included  studies.
Discussion:  The  intrawound  application  of  vancomycin  powder  in addition  to  intravenous  administration
of  antibiotics  may  signiﬁcantly  reduce  the  risk  of  deep  infection  after  spinal  surgeries.  Further  studies
with  large  sample  size  and  high  quality  are needed  to provide  more  evidences.
Level of evidence:  II.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
The deep infection, which is very difﬁcult to treat, repre-
ents a several complication of spinal surgeries[1] with a reported
ncidence rate ranging from 1.9–13% [2–6]. Additional surgical
reatments are needed for the exploration, sampling and debride-
ent. Meanwhile, the antibiotics therapy has to be intensively
pplied to eradicate the underlying infection. This complication
igniﬁcantly lengthens hospital stay, causes excessive health care
osts and increases morbidities [7,8].
∗ Corresponding author. Department of Hand-, Plastic and Reconstructive Surgery,
urn Center, University of Heidelberg, BG Trauma Center Ludwigshafen, Ludwig
uttmann Street 13, 67071 Ludwigshafen, Germany. Tel.: +49 621 6810 2328.
E-mail address: xionglingyun1986@163.com (L. Xiong).
1 First authors of this work.
http://dx.doi.org/10.1016/j.otsr.2014.05.022
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.Prophylactic antibiotics are usually administrated systemically
to prevent deep infections after spinal surgeries. However, the
local ischemia, hematoma and seroma of surgical site impair the
intravenous delivery of antibiotics, leading to inadequate local con-
centrations [9] Additionally, it has been reported that major spine
infections are bacterial monomicrobial caused by Staphylococcus
aureus [10]. Methicillin-resistant S. aureus (MRSA) [11]. which has
widely spread, results in unsatisfactory responses to cephalosporin
administrations.
To decrease the deep infection rate, adjunctive prophylaxes to
cephalosporin administrations are primarily studied in past sev-
eral decades. Recently, several groups reported the intrawound
application of vancomycin powder in addition to intravenous
administration of antibiotics in spinal surgeries; they demonstrated
that it is easy, cost-efﬁcient and promising for prophylaxis of deep
infections [5,12–18]. We  conducted the present meta-analysis to
quantitatively summarize the effect of intrawound vancomycin
powder application in addition to intravenous administration of
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ntibiotics in spinal surgeries, and providing evidences of further
linical applications.
. Materials and methods
.1. Study source
A systematic literature search was performed using PubMed
nd EMBASE databases, aiming on studies published until March,
014. The object was limited to “human”. Medical Subject Head-
ng (MeSH) terms “vancomycin”, “local”, and the other individual
orresponding free terms were used. A comprehensive search of all
eference lists of review articles was conducted to ﬁnd potential
elevant studies.
Inclusion criteria were as follows: (a) case-control design, (b)
ample sizes of both control and experiment groups were equal
o or larger than 10, (c) antibiotics were administrated intra-
enously before and after surgeries, (d) patients received spinal
urgeries with or without intrawound vancomycin powder applica-
ion, (e) follow-up equal to or longer than 1 month, (f) postoperative
eep infections were diagnosed by bacterial cultures, (g) the effect
f intrawound vancomycin powder application on postoperative
nfection was described by odds ratios (OR) and 95% conﬁdential
ntervals (95% CI), or ORs (95% CI) can be calculated from the pub-
ished data.
Studies were excluded on the basis of following criteria: (a)
eviews, meta-analyses, abstracts or letters, (b) sample sizes of con-
rol or experiment group smaller than 10 pro group, (c) overlapping
rticles, (d) superﬁcial infections, (e) the postoperative deep infec-
ion was not diagnosed by bacterial culture, (f) follow-up shorter
han 1 month, (g) ORs or 95% CIs cannot be got from the published
ata.
Two individual investigators (QP and GJ) evaluated indepen-
ently search results using predeﬁned inclusion and exclusion
riteria. Disagreements between two investigators were resolved
y a third investigator (LX) after re-checking the original article and
 discussion on evidences.
.2. Data extraction and quality evaluation
Following data were extracted: ﬁrst authors, years of pub-
ication, countries, sample sizes, participants’ characteristics,
ancomycin powder doses, vancomycin-related adverse reactions,
esponsible pathogens for infections, ORs (95% CIs) or data for OR
95% CI) calculation if there was no direct OR in article.
Qualities of included studies were evaluated using the
ewcastle–Ottawa Scale (NOS). Each study was assessed based on
hree broad perspectives, including selection, comparability and
xposure, with a score ranging from 0 to 9. We  considered a study
ith an NOS score of 0–3, 4–6, 7–9 as low, medium, or high quality.
.3. Statistical analysis
Effect measures of interest were OR and corresponding 95% CI.
he OR (95% CI) was calculated by using 2 × 2 contingency table
f intrawound vancomycin powder application and postoperative
eep infection (SPSS 17.0, SPSS Inc., USA), if the original article had
ot provided it.
Statistical heterogeneity among studies was evaluated using
he Cochran’s Q statistic, P values, and I2 statistics (Stata 12.0,
tata Corporation, USA). Heterogeneity was considered signiﬁcant
f I2 value > 50% or P < 0.05. Considering demographics of different
ohorts, differences in performed surgeries and operators’ experi-
nces, the random-effects model was used to calculate the pooled
R (95% CI).Fig. 1. Flow chart of article selection.
One-study - removed sensitivity analyses were performed to
reﬂect the inﬂuence of the individual data and speciﬁc studies on
the summary OR. Subgroup analyses, univariante and multivari-
able regression analyses were performed to ﬁnd impact factors of
the summary OR if sufﬁcient studies were available. P < 0.05 was
considered statistically signiﬁcant. Publication bias was  explored
by Harbord-Egger analysis [19] if sufﬁcient studies were available.
P < 0.05 was considered statistical signiﬁcant.
3. Results
A total of 2164 studies have been searched in PubMed and
EMBASE (Fig. 1). Two  thousand one hundred and ﬁfty-four stud-
ies were excluded basing on their titles and abstracts. Rest,
11 studies were checked in full-text. Three studies [15,18,20]
were excluded because of inadequate data on deep infection,
deep infection was not determined by bacterial culture and the
lack of follow-up information, respectively. Finally, eight studies
[5,12–14,16,17,21,22]were included in this meta-analysis.
3.1. Characteristics and NOS scores of included studies
Eight included studies were published between 2011 and 2014.
A total of 4592 patients were included. Characteristics of these stud-
ies and NOS scores were shown in Table 1. Clinical details were
shown in Table 2.
3.2. The effect of intrawound vancomycin powder application on
postoperative infections
The pooled OR (95% CI) was 0.22 (0.07–0.63). I2 value was 65.2%
(P = 0.005). Fig. 2 shows detail results.
3.3. Sensitivity analysis, subgroup analysis, meta-regression, and
publication bias
In sensitivity analyses, by omitting one study at each time,
the pooled ORs were not qualitatively changed, ranging from
0.23 to 0.47. Publications of two teams [21,22], which demon-
strated insigniﬁcant effects of vancomycin on reducing deep
infection, could be the cause of signiﬁcant heterogeneity. The
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Table  1
Patient characteristics and quality of included studies.
First author Country Group with local vancomycin Group without local vancomycin Follow-up NOS score
(year) Sample size Female Age Sample size Female Age
F. Sweet (2011) USA 911 51% 56.0 821 48% 53.0 Mean 3.4 years 4
K.  O’Neill (2011) USA 56 37% 43.0 54 35% 45.0 More than 2 months in 76% patients 5
J.  Pahys (2013) USA 195 – – 806 – – – 4
R.  Strom (2013) USA 79 43% 60.0 92 40% 60.0 More than 1 year 4
C.  Caroom (2013) USA 40 – 59.8 72 – 56.4 More than 6 months 4
R.  Strom (2013) USA 156 67% 64.0 97 46% 64.0 More than 1 year 4
V.  Tubaki (2013) India 433 46% 44.3 474 42% 46.6 More than 3 months 5
J.  Martin (2014) USA 156 65% 63.4 150 67% 62.7 1 month 4
NOS: Newcastle–Ottawa Scale; –: no information.
Table 2
Clinical details of included studies.
First author Surgeries Perioperative
intravenous antibiotics
Wound
irrigation
Intrawound
vancomycin
dose (g)
Vancomycin
Related
complications
Pathogens of infected cases
F. Sweet Thoracic and
lumbar
instrumented
spinal fusion
Cefazolin – 2 No S. aureus,  coagulase
negative staphylococcus organism
K.  O’Neill Posterior spinal
fusion using
pedicle screw
and rod
instrumentation
Cefazolin or
clindamycin
Saline (2 Litter) 1 No MRSA, Polymicrobial
J.  Pahys Posterior cervical
surgery
Cephalosporin – 0.5 – MSSA
R.  Strom Occipitocervical
and cervicothoracic
fusion
Cefazolin or
vancomycin
Saline with
bacitracin
(3 Litter)
1 No MSSA, MRSA, coagulase - negative
staphylococci, Gram-negative rods
C.  Caroom Posterior cervical
decompression
and
instrumentation
– Saline
(volume not
described)
1 No MRSA, Methicillicin - resistant
Coagulase - negative staphylococci
species
R.  Strom Lumbar
laminectomy and
posterior fusion
Cefazolin or
vancomycin
Saline with
bacitracin
(3 Litter)
1 No MSSA, MRSA, coagulase - negative
Staphylococci, gram - negative rods
V.  Tubaki Open spine surgery Cefuroxime Saline (1 Litter) 1 – S. aureus,  Klebsiella
J.  Martin Thoracolumbar and
lumbar spinal
deformity surgery
Cefazolin,
clindamycin,
ciproﬂoxacin,
piperacillin/tazobactam,
or vancomycin
Saline (2 Litter) 2 – MSSA, MRSA, coagulase - negative
staphylococci, Enterobacter cloacae,
Serratia marcescens, Klebsiella
pneumoniae,
Citrobacter freundii
MRSA: Methicillin – resistant S. aureus;  MSSA: Methicillin – sensitive S. aureus; –: no information.
Fig. 2. The pooled odds ratio of the intrawound application of vancomycin powder in addition to intravenous administration of antibiotics on the deep infection after spinal
surgeries.
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eterogeneity of pooled OR largely decreased to an insigniﬁcant
evel (I2 value = 0.0%, P = 0.784) after the omitting of their publica-
ions.
The amount of included studies was too small to conduct any
ufﬁcient additional analysis of subgroup, meta-regression or pub-
ication bias.
. Discussion
This is the ﬁrst meta-analysis which focuses specially on the
ombination of intrawound application of vancomycin powder and
ntravenous administration of antibiotics for the prophylaxis of
eep infection after spine surgery. Findings of the present meta-
nalysis suggest that this technique could signiﬁcantly reduce
atients’ risk of deep infection after spinal surgeries.
Systemic administration of the ﬁrst- or second-generation
ephalosporins is commonly used as perioperative prophylaxis.
lthough MRSA has widely spread in past decades, the rou-
ine surgical prophylaxis using vancomycin as a primary agent
s not popular because of their similar clinical effectiveness to
ephalosporins and higher costs.
However, because of increasing concerns about MRSA and
oagulase-negative staphylococcus, prophylactic vancomycin is
ecommended in several surgeries, such as the replacement of arti-
cial joints and cardiac surgeries, of which the consequences of
ostoperative infections are severe. It is widely agreed that the
eep infection after spinal surgeries is serious. It may  lead to neu-
ological deﬁcit of legs, spinal instability, bony non-union or spinal
eformity. Moreover, it signiﬁcantly lengthens hospital stays and
ncreases the burden of health care costs.
Compared to intravenous administration, the intrawound use
f vancomycin for adjunctive prophylaxis in spinal surgeries is
ttractive because of the higher local concentration, less systemic
ntibiotic exposure and lower cost. As expected, the present study
ound that this technique, of which the pooled OR (95% CI) was
.22 (0.07–0.63), may  signiﬁcantly decrease postoperative deep
nfection. H. Chiang, et al. [23] have recently reported that the intra-
ound use of vancomycin appears to protect against the infection
f surgical site, the result of the present study agree with their con-
lusion. In addition to that, our analysis focussed more specially on
he effect of this technique in deep infection after spine surgeries,
ncluded more original publications and could provide estimation
ith more strength and more preciseness.
Previously, F. Sweet, et al. [12] reported that the mean van-
omycin level in wound remained 128 g/mL on the third day after
ntrawound application of 2 g vancomycin powder. I. Gans, et al.
15] reported that the systemic vancomycin level was lower than
.0 g/mL on the ﬁrst postoperative day in 49 out of 50 patients who
eceived 0.5 g intrawound vancomycin. There was one patient with
 systemic level of 3.2 g/mL but it was lower than 2.0 g/mL on the
ourth day after surgery. Results of these two studies suggest that
he intrawound application could efﬁciently deliver vancomycin to
urgical sites with very low systemic toxicities. Studies which par-
llel test intrawound and systemic vancomycin level are needed to
urther prove it.
Moreover, it has been demonstrated that about 300,000 US dol-
ars per 1000 cases would be saved if the infection rate is decreased
rom 2.5% to 1.0 [12,18]. The reduction in health care cost is sig-
iﬁcant considering the vancomycin powder only costs 12–44 US
ollars per case [12,18,20]. The reduction of care cost could repre-
ent another advantage of this technique.Signiﬁcant heterogeneity was detected among included stud-
es. Two publications, which demonstrated that the intrawound
se of vancomycin for adjunctive prophylaxis in spinal surgeries
oes not signiﬁcantly decrease the deep infection rate, may  be the
[Surgery & Research 100 (2014) 785–789
source of heterogeneity, as indicated by the study-omitting analy-
sis. It could be inferred that potential risk factors which impair the
effect of intrawound use of vancomycin may  exist. Further cohort
studies should pay more attention on the analysis of risk factors
in order to optimize the patient selection and improve the clinical
performance.
Several limitations raised in this study should be considered.
First, sample sizes of several included studies are relatively small,
their results may  be biased because of patient selection; the present
meta-analysis cannot rule out such bias. Second, the quantity of
included studies is small, which may  reduce the strength of our
results. Third, qualities of included studies were relatively low.
Fourth, signiﬁcant heterogeneities may  limit generalization. Fur-
thermore, no subgroup analysis, meta-regression or publication
bias test was performed because of inadequate number of eligible
studies.
In conclusion, the present meta-analysis found that the
intrawound application of vancomycin powder in addition to intra-
venous administration of antibiotics may signiﬁcantly reduce the
risk of deep infection after spinal surgeries. However, the num-
ber of available studies is limited, it is important that larger and
well-designed studies are performed in the future.
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